Canadian Drug Regulator Queries Pfizer on DNA Fragment Sizes in mRNA COVID-19 Vaccine

The Canadian drug regulatory body has reportedly asked Pfizer to provide data regarding the size of the DNA fragments in its mRNA COVID-19 vaccine. This move comes as a response to growing concerns about potential genomic implications.

Concerns About Genomic Implications

There are rising apprehensions about the possible genomic implications of the mRNA COVID-19 vaccine. These concerns are primarily based on the potential that the vaccine could interfere with human DNA, prompting the Canadian drug regulator to seek more information from Pfizer.

Pfizer's Response to the Request

As of now, Pfizer has not publicly responded to the request from the Canadian drug regulator. It remains to be seen how the pharmaceutical giant will address these concerns and what data they will provide to assuage the fears surrounding the mRNA COVID-19 vaccine.

As we delve deeper into the world of mRNA vaccines and their potential implications, it's essential to keep an open mind and stay informed. What are your thoughts on this development? Do you think Pfizer will be able to adequately address these concerns? Share this article with your friends and start a conversation. Don't forget to sign up for the Daily Briefing, delivered to your inbox every day at 6pm.